+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Celecoxib Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 89 Pages
  • April 2023
  • Region: Global
  • Prof Research
  • ID: 5771531
Description Jump to:

Quick Summary:

In a global healthcare environment that demands precision, understanding, and forward-thinking, the use of Celecoxib continues to be a topic of prime importance. This comprehensive report offers pertinent insights into the world of Celecoxib, its applications, and its market dynamics across key geographies such as North America, South America, Asia & Pacific, Europe, and MEA.

Our market research report is a master guide, outlining essential data on regional supply and demand, major players, and price perspectives. It offers a comprehensive competitor analysis, covering not only global key players but also smaller competitors in the domain. The report sets an unmatched benchmark in capturing critical business information, SWOT analysis, and relevant market share data. Further, it explores the varied applications of Celecoxib and the types it is available in, providing a well-curated insight for strategy development and market navigation. It covers renowned companies like Pfizer, Shire, Teva, Mylan and many more thereby facilitating informed decision-making for stakeholders.

This report describes the global market size of Celecoxib from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028.

For the geography segment, regional supply, demand, major players, price is presented from 2018 to 2028.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Celecoxib as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Rheumatoid Arthritis
  • Osteoarthritis
  • Acute Pain
  • Musculoskeletal Pain
  • Others

Types Segment:

  • 50mg Celecoxib
  • 100mg Celecoxib
  • 200mg Celecoxib
  • 400mg Celecoxib

Companies Covered:

  • Pfizer
  • Shire
  • Teva
  • Mylan
  • Chengdu Suncadia Pharmaceuticals
  • Jiangsu Chiatai Qingjiang Pharmaceutical
  • Anhui Heyi Chemical
Base Year: 2023
Historical Data: from 2018 to 2022
Forecast Data: from 2023 to 2028


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Celecoxib Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Celecoxib Market in North America (2018-2028)
8.1 Celecoxib Market Size
8.2 Celecoxib Market by End Use
8.3 Competition by Players/Suppliers
8.4 Celecoxib Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Celecoxib Market in South America (2018-2028)
9.1 Celecoxib Market Size
9.2 Celecoxib Market by End Use
9.3 Competition by Players/Suppliers
9.4 Celecoxib Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Celecoxib Market in Asia & Pacific (2018-2028)
10.1 Celecoxib Market Size
10.2 Celecoxib Market by End Use
10.3 Competition by Players/Suppliers
10.4 Celecoxib Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Celecoxib Market in Europe (2018-2028)
11.1 Celecoxib Market Size
11.2 Celecoxib Market by End Use
11.3 Competition by Players/Suppliers
11.4 Celecoxib Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Celecoxib Market in MEA (2018-2028)
12.1 Celecoxib Market Size
12.2 Celecoxib Market by End Use
12.3 Competition by Players/Suppliers
12.4 Celecoxib Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Celecoxib Market (2018-2023)
13.1 Celecoxib Market Size
13.2 Celecoxib Market by End Use
13.3 Competition by Players/Suppliers
13.4 Celecoxib Market Size by Type
Chapter 14 Global Celecoxib Market Forecast (2023-2028)
14.1 Celecoxib Market Size Forecast
14.2 Celecoxib Application Forecast
14.3 Competition by Players/Suppliers
14.4 Celecoxib Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Celecoxib Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Celecoxib Revenue, Gross Margin and Market Share (2018-2023)
15.2 Shire
15.2.1 Company Profile
15.2.2 Main Business and Celecoxib Information
15.2.3 SWOT Analysis of Shire
15.2.4 Shire Celecoxib Revenue, Gross Margin and Market Share (2018-2023)
15.3 Teva
15.3.1 Company Profile
15.3.2 Main Business and Celecoxib Information
15.3.3 SWOT Analysis of Teva
15.3.4 Teva Celecoxib Revenue, Gross Margin and Market Share (2018-2023)
15.4 Mylan
15.4.1 Company Profile
15.4.2 Main Business and Celecoxib Information
15.4.3 SWOT Analysis of Mylan
15.4.4 Mylan Celecoxib Revenue, Gross Margin and Market Share (2018-2023)
15.5 Chengdu Suncadia Pharmaceuticals
15.5.1 Company Profile
15.5.2 Main Business and Celecoxib Information
15.5.3 SWOT Analysis of Chengdu Suncadia Pharmaceuticals
15.5.4 Chengdu Suncadia Pharmaceuticals Celecoxib Revenue, Gross Margin and Market Share (2018-2023)
15.6 Jiangsu Chiatai Qingjiang Pharmaceutical
15.6.1 Company Profile
15.6.2 Main Business and Celecoxib Information
15.6.3 SWOT Analysis of Jiangsu Chiatai Qingjiang Pharmaceutical
15.6.4 Jiangsu Chiatai Qingjiang Pharmaceutical Celecoxib Revenue, Gross Margin and Market Share (2018-2023)
15.7 Anhui Heyi Chemical
15.7.1 Company Profile
15.7.2 Main Business and Celecoxib Information
15.7.3 SWOT Analysis of Anhui Heyi Chemical
15.7.4 Anhui Heyi Chemical Celecoxib Revenue, Gross Margin and Market Share (2018-2023)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Celecoxib Report
Table Data Sources of Celecoxib Report
Table Major Assumptions of Celecoxib Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Celecoxib Picture
Table Celecoxib Classification
Table Celecoxib Applications
Table Drivers of Celecoxib Market
Table Restraints of Celecoxib Market
Table Opportunities of Celecoxib Market
Table Threats of Celecoxib Market
Table Covid-19 Impact For Celecoxib Market
Table Raw Materials Suppliers
Table Different Production Methods of Celecoxib
Table Cost Structure Analysis of Celecoxib
Table Key End Users
Table Latest News of Celecoxib Market
Table Merger and Acquisition
Table Planned/Future Project of Celecoxib Market
Table Policy of Celecoxib Market
Table 2018-2028 North America Celecoxib Market Size
Figure 2018-2028 North America Celecoxib Market Size and CAGR
Table 2018-2028 North America Celecoxib Market Size by Application
Table 2018-2023 North America Celecoxib Key Players Revenue
Table 2018-2023 North America Celecoxib Key Players Market Share
Table 2018-2028 North America Celecoxib Market Size by Type
Table 2018-2028 United States Celecoxib Market Size
Table 2018-2028 Canada Celecoxib Market Size
Table 2018-2028 Mexico Celecoxib Market Size
Table 2018-2028 South America Celecoxib Market Size
Figure 2018-2028 South America Celecoxib Market Size and CAGR
Table 2018-2028 South America Celecoxib Market Size by Application
Table 2018-2023 South America Celecoxib Key Players Revenue
Table 2018-2023 South America Celecoxib Key Players Market Share
Table 2018-2028 South America Celecoxib Market Size by Type
Table 2018-2028 Brazil Celecoxib Market Size
Table 2018-2028 Argentina Celecoxib Market Size
Table 2018-2028 Chile Celecoxib Market Size
Table 2018-2028 Peru Celecoxib Market Size
Table 2018-2028 Asia & Pacific Celecoxib Market Size
Figure 2018-2028 Asia & Pacific Celecoxib Market Size and CAGR
Table 2018-2028 Asia & Pacific Celecoxib Market Size by Application
Table 2018-2023 Asia & Pacific Celecoxib Key Players Revenue
Table 2018-2023 Asia & Pacific Celecoxib Key Players Market Share
Table 2018-2028 Asia & Pacific Celecoxib Market Size by Type
Table 2018-2028 China Celecoxib Market Size
Table 2018-2028 India Celecoxib Market Size
Table 2018-2028 Japan Celecoxib Market Size
Table 2018-2028 South Korea Celecoxib Market Size
Table 2018-2028 Southeast Asia Celecoxib Market Size
Table 2018-2028 Australia Celecoxib Market Size
Table 2018-2028 Europe Celecoxib Market Size
Figure 2018-2028 Europe Celecoxib Market Size and CAGR
Table 2018-2028 Europe Celecoxib Market Size by Application
Table 2018-2023 Europe Celecoxib Key Players Revenue
Table 2018-2023 Europe Celecoxib Key Players Market Share
Table 2018-2028 Europe Celecoxib Market Size by Type
Table 2018-2028 Germany Celecoxib Market Size
Table 2018-2028 France Celecoxib Market Size
Table 2018-2028 United Kingdom Celecoxib Market Size
Table 2018-2028 Italy Celecoxib Market Size
Table 2018-2028 Spain Celecoxib Market Size
Table 2018-2028 Belgium Celecoxib Market Size
Table 2018-2028 Netherlands Celecoxib Market Size
Table 2018-2028 Austria Celecoxib Market Size
Table 2018-2028 Poland Celecoxib Market Size
Table 2018-2028 Russia Celecoxib Market Size
Table 2018-2028 MEA Celecoxib Market Size
Figure 2018-2028 MEA Celecoxib Market Size and CAGR
Table 2018-2028 MEA Celecoxib Market Size by Application
Table 2018-2023 MEA Celecoxib Key Players Revenue
Table 2018-2023 MEA Celecoxib Key Players Market Share
Table 2018-2028 MEA Celecoxib Market Size by Type
Table 2018-2028 Egypt Celecoxib Market Size
Table 2018-2028 Israel Celecoxib Market Size
Table 2018-2028 South Africa Celecoxib Market Size
Table 2018-2028 Gulf Cooperation Council Countries Celecoxib Market Size
Table 2018-2028 Turkey Celecoxib Market Size
Table 2018-2023 Global Celecoxib Market Size by Region
Table 2018-2023 Global Celecoxib Market Size Share by Region
Table 2018-2023 Global Celecoxib Market Size by Application
Table 2018-2023 Global Celecoxib Market Share by Application
Table 2018-2023 Global Celecoxib Key Vendors Revenue
Figure 2018-2023 Global Celecoxib Market Size and Growth Rate
Table 2018-2023 Global Celecoxib Key Vendors Market Share
Table 2018-2023 Global Celecoxib Market Size by Type
Table 2018-2023 Global Celecoxib Market Share by Type
Table 2023-2028 Global Celecoxib Market Size by Region
Table 2023-2028 Global Celecoxib Market Size Share by Region
Table 2023-2028 Global Celecoxib Market Size by Application
Table 2023-2028 Global Celecoxib Market Share by Application
Table 2023-2028 Global Celecoxib Key Vendors Revenue
Figure 2023-2028 Global Celecoxib Market Size and Growth Rate
Table 2023-2028 Global Celecoxib Key Vendors Market Share
Table 2023-2028 Global Celecoxib Market Size by Type
Table 2023-2028 Celecoxib Global Market Share by Type

Companies Mentioned

  • Pfizer
  • Shire
  • Teva
  • Mylan
  • Chengdu Suncadia Pharmaceuticals
  • Jiangsu Chiatai Qingjiang Pharmaceutical
  • Anhui Heyi Chemical

Methodology

Loading
LOADING...

Related Topics

Related Reports

Overcoming Cancers Resistant to HER-2 Antibodies. Breaking Tolerance to Antibody-Mediated Immunotherapy Volume 2 - Product Image

Overcoming Cancers Resistant to HER-2 Antibodies. Breaking Tolerance to Antibody-Mediated Immunotherapy Volume 2

  • Book
  • 250 Pages
Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Report and Forecast 2024-2032 - Product Image

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Cyclo-oxygenase 2 inhibitors - Pipeline Insight, 2024 - Product Image

Cyclo-oxygenase 2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • 90 Pages
  • Global
From
US Postoperative Acute Pain - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Image

US Postoperative Acute Pain - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • 216 Pages
  • United States
From
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update - Product Image

Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update

  • Report
  • 92 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.